A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...

In crisis mode, Ravi asks Nicola for dealer Okie’s number so he can enlist him to do a dodgy job – but is forced to hide his ...

Six years later, the result is “Young Firecrackers,” a five-part memoir written by Rehn and four of his high school friends who survived addiction: Ashley Mercurio, Ryan Bernstein, Andrew Theriot and ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...

Nearly 38,000 Indiana students have tried psychoactive Delta THC products — a direct result of a loophole in state marijuana ...

Antibiotic efflux pumps are expressed in all microbes, where they serve as crucial gatekeepers in resisting the cellular ...

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make ...

Although Gentamicin is already approved by the U.S. Food and Drug Administration (FDA), its use in people is limited. It can ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.